Uncategorized
pSivida Corp. Reports Third Quarter FY 2015 Results
WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida reports third quarter FY 2015 results; Clear FDA Regulatory Path for Medidur for Posterior Uveitis; NDA filing planned in first half of 2017
